ロード中...
New treatments for chronic hepatitis C
Treatments for chronic hepatitis C has evolved significantly in the past 15 years. The standard of care (SOC) is peginterferon alfa-2a/-2b with ribavirin for 48 weeks or 24 weeks in patients infected with HCV genotype 1 or 2/3, respectively. The treatment duration can be individualized based on the...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Association for the Study of the Liver
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3304602/ https://ncbi.nlm.nih.gov/pubmed/20924208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/kjhep.2010.16.3.263 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|